Pharmacoeconomic analysis of the new oral antifungal agents used to treat toenail onychomycosis in the USA

Int J Dermatol. 1999 Sep:38 Suppl 2:53-64. doi: 10.1046/j.1365-4362.1999.00012.x.
No abstract available

Publication types

  • Meta-Analysis

MeSH terms

  • Administration, Oral
  • Antifungal Agents / therapeutic use*
  • Cost-Benefit Analysis
  • Drug Costs / statistics & numerical data
  • Economics, Pharmaceutical*
  • Fluconazole / therapeutic use
  • Foot Dermatoses / drug therapy*
  • Griseofulvin / therapeutic use
  • Humans
  • Itraconazole / therapeutic use
  • Naphthalenes / therapeutic use
  • Onychomycosis / drug therapy*
  • Terbinafine
  • United States

Substances

  • Antifungal Agents
  • Naphthalenes
  • Itraconazole
  • Griseofulvin
  • Fluconazole
  • Terbinafine